Table 2.
Admission days | Samples | Methods | Antibody spectrum |
---|---|---|---|
Day 0 | Blood and CSF | CBA and TBA | NMDAR, GABABR, LGI1, Caspr2, AMPAR1, AMPAR2, GAD, MOG |
Day 7 | Blood and CSF |
CBA and paraneoplastic antibody OR TBA |
NMDAR, LGI1, GABABR, CASPR2, AMPAR1, AMPAR2, IgLON5, DPPX, GAD65, mGluR5, GlyR, D2R Paraneoplastic antibody: Hu, Yo, Ri, CV2(CRMP5), Ma1, Ma2, Amphiphysin, SOX1, Tr (DNER), Zic4, GAD65, PKCγ, Recoverin, Titin |
Day 14 | Blood and CSF | CBA | MDAR, GABABR, LGI1, Caspr2, AMPAR1, AMPAR2, GAD, MOG |
Day 15–60 | Blood and CSF | CBA ± TBA | MDAR, GABABR, LGI1, Caspr2, AMPAR1, AMPAR2, GAD, MOG |
1/3/6/12 months | Blood | CBA | Re-examinations for autoimmune-positive patients |